Synonyma:4-[(3-endo)-3-Hydroxy-8-azabicyclo[3.2.1]oct-8-yl]naphthalene-1-carbonitrile;AC-262536;AC-262,356;4-(3-endo-Hydroxy-8-azabicyclo[3.2.1]oct-8-yl)naphthalene-1-carbonitrile
Other names: AC-262 356/AC-262,356 Sarms/AC-262356
CAS:870888-46-3
MF:C18H18N2O
storage temp. 2-8°C
AC-262,536 medicamentum est quod ac receptaculum modulatorem selectivum androgenium agit. Chemice habet endo-exo isomerism, cum endo forma activa. Agonista ex parte agit in receptorem androgenium cum Ki of 5nM, et nullam notabilem affinitatem ad alios receptos probatos. In studiis animalis maximum effectum circa 66% of the anabolic action of test osterone, but only around 27% of its potency as an androgen.
AC-262536 is a drug developed by Acadia Pharmaceuticals which acts as a selective androgen receptor modulator (SARM).
Chemice habet endo-exo isomerism, cum endo forma activa. Agonista ex parte agit in receptorem androgenium cum Ki of 5nM, et nullam notabilem affinitatem ad alios receptos probatos. In studiis animalis maximum effectum circa 66% of the anabolic action of testosterone, but only around 27% of its potency as an androgen.
1.helping improve the function of the hippocampus (which could stave off the onset of Alzheimer’s disease)
and the possible prevention of prostate cancer. Tests data reveal that this SARM can suppress the activity of dihydroxytestosterone (DHT) in the human prostate cancer cell.
2.Scientists also found out that AC-262,536’s effects in keeping the prostate’s ideal size were 14x weaker than that of testosterone.
3.Acts On Pituitary Function
4.Helps With Muscle Growth
5.May Help With Alzheimer’s Disease
